Iadademstat in combination with azacitidine in patients with newly diagnosed acute myeloid leukaemia (ALICE): an open-label, phase 2a dose-finding study
Olga Salamero, Antonieta Molero, José Antonio Pérez‐Simón, Montserrat Arnán, Rosa Coll, Sara Garcia-Ávila, Evelyn Acuña‐Cruz, Isabel Cano, Tim C. P. Somervaille, S. Gutiérrez, María Isabel Arévalo, Jordi Xaus, Carlos Buesa, Ana Limón, Douglas V. Faller, Francesc Bosch, Pau Montesinos
Topics & Concepts
Myeloid leukaemiaAzacitidineAlice (programming language)MedicineOpen labelOpen label studyOncologyPediatricsInternal medicineComputer scienceAdverse effectChemistryDNA methylationGeneBiochemistryProgramming languageGene expressionAcute Myeloid Leukemia ResearchHistone Deacetylase Inhibitors ResearchEpigenetics and DNA Methylation